INST synthesizes hybrid compound that can inhibit Cancer cells

▴ INST comes up with Cancer inhibiting chemicals
INST synthesizes inorganic-organic hybrid compound that can inhibit breast, lung & liver cancer cells

Scientists from the Institute of Nano Science & Technology (INST), Mohali, an autonomous institute of the Department of Science and Technology Government of India, have synthesized a novel inorganic-organic hybrid compound that can inhibit breast, lung, and liver cancer cells, opening up new possibilities for metallodrugs.

The solid compound based on phosphomolybdate cluster, an inorganic salt of phosphomolybdic acid, belongs to the Polyoxometalates (POMs) family, which had earlier been identified to have antitumor potential. The team of scientists led by Dr. Monika Singh and Dr. Deepika Sharma has chalked out the mechanism by which the compound kills the cancer cells. The research has been published in the journal Dalton Transactions.

POMs are an evolving class of inorganic metal oxides, which over the last decades, established promising biological activities by the virtue of their great diversity in structures and properties.

In order to probe into the mechanism of how the cancer cells are attacked by the compound, the team synthesized it by hydrothermal method. The aqueous mixture of sodium molybdate, phosphorus acid, and bipyridine was heated in an acetate buffer solution of pH 4 at 160 °C for 72 hours. In vitro cytotoxicity of the compound was determined on breast cancer (MCF-7), lung cancer (A549) and liver cancer (HepG2) cells by the conventional MTT assay (used for assessing cell metabolic activity). The cytotoxic effect observed for the compound on the various cancer cell lines was further compared with that of a routinely used chemotherapeutic agent, Methotrexate (TCI), by the MTT assay.

The mechanism of cell death occurring in breast cancer (MCF-7), lung cancer (A549) and liver cancer (HepG2) cells were evaluated using an Alexa Fluor 488 annexin V/dead cell apoptosis kit (Invitrogen). To determine the effect of the synthesized materials on the cell division, cell cycle analysis for the MCF-7, A549, and HepG2 cell lines was done by using flow cytometry. The in vitro results showed that this hybrid solid is less toxic towards normal cells, and its antitumor activity was also found to be comparable with that of a routinely used chemotherapeutic agent, Methotrexate (MTX).

In the past few decades, POMs have evolved as a promising candidate for future metallodrugs for combating cancer. The compound synthesized by the INST team could open new avenues for antitumor applications.

Tags : #PhosphomolybdateCluster #INSTMohali #BreastCancer #LungCancer #CancerCells

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-





Trending Now

India Covid Vaccine Rollout : A detailed state wise update Jan 19,2021January 19, 2021
Lakshadweep reports first Covid-19 case January 19, 2021
Country's COVID-19 recovery rate reaches 96.66 per cent; more than 3, 81000 people vaccinated so farJanuary 19, 2021
Biden stays the travel ban for passengers from UK, Brazil and EU countriesJanuary 19, 2021
US faces 400000 lakh deaths due to CoronavirusJanuary 19, 2021
Sirnaomics announces first patient dosed In phase 2a study of STP705January 18, 2021
Andhra Pradesh: 332 locations identified for rollout of COVID-19 vaccinationJanuary 18, 2021
COVID-19 Vaccination begins in Kargil at District HospitalJanuary 18, 2021
Jharkhand: Covid vaccination drive underway at all 49 centresJanuary 18, 2021
Higher coffee intake may be linked to lower prostate cancer riskJanuary 18, 2021
Vaccination drive against Covid-19 being carried out four days a week in West BengalJanuary 18, 2021
Short term low carbohydrate diet linked to remission of type 2 diabetesJanuary 18, 2021
Enhertu approved in the US for the treatment of patients with previously treated HER2-positive advanced gastric cancerJanuary 18, 2021
How important is nutrition for health?January 18, 2021
GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient solid cancers at ASCO Gastrointestinal Cancers SymposiumJanuary 18, 2021
Avian Influenza confirmed in crow samples from Haridwar, Lansdowne forest range of UttarakhandJanuary 18, 2021
National COVID-19 recovery rate improves to 96.59 per centJanuary 18, 2021
Over 5, 48, 000 COVID samples tested in country in last 24 hoursJanuary 18, 2021
India's vibrant Biotechnology sector ; A failsafe investment optionJanuary 18, 2021
Total 447 adverse events reported during COVID vaccination: Health Ministry January 18, 2021